- In the Phase 2 FLOW study for the treatment of OSA, sulthiame met the primary endpoint across all doses, and significantly improved multiple efficacy measures, while…
Apnimed Announces Publication in The Lancet of Positive Phase 2 Results Demonstrating Sulthiame’s Efficacy in Obstructive Sleep Apnea
